@11112011 breakthrough cases also seem to be more virulent and transmissible, so in a few years we'll all either be on our 6th booster or ivermectin
@11112011 off patent, if Merck want to make money than have to sell fresh gear not old stuff
@icedquinn @11112011 compared to other solutions (looking at you redesemvir) ivermectin is stunning in early treatment
but yeah, late treatment doesn't work quite as well.